Abstract PS5-02-10: Pyrotinib plus capecitabine with or withoutradiotherapyin patients with HER2-positive metastatic breast cancer and brain metastases: Amulticenter, retrospective-prospective, real-world study in China (Post-PERMEATE)
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institutions: Zhengzhou University, Henan Cancer Hospital, Peking University Cancer Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Chinese PLA General Hospital, First Hospital of Jilin University, Shandong Tumor Hospital, Shandong First Medical University, Wuhan Union Hospital, Huazhong University of Science and Technology, Jiangsu Province Hospital, Affiliated Hospital of Qingdao University, Xinjiang Medical University, Tumor Hospital of Xinjiang Medical University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Central South University, Hunan Cancer Hospital, Hebei Medical University, Fourth Hospital of Hebei Medical University, Sun Yat-sen Memorial Hospital, Hubei Cancer Hospital, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129434888
Cites:
Cited by:
Related to: